Media Newsroom of

ImmunoBiochem Corporation

Follow on Social Network

ImmunoBiochem Corporation is a biotechnology company committed to addressing unmet medical need in oncology through research and development of novel, targeted biological therapeutics.

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

ImmunoBiochem Corporation, a Canadian biopharmaceutical company developing novel biological therapeutics, has completed a new round of financing led by angel investors and the company’s founding investor. ImmunoBiochem has also expanded its operations and is now located at Johnson & Johnson…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login